行情

CRY

CRY

CryoLife
NYSE

实时行情|Nasdaq Last Sale

22.96
-0.44
-1.88%
盘后: 22.96 0 0.00% 17:37 09/28 EDT
开盘
23.20
昨收
23.40
最高
23.20
最低
22.89
成交量
12.20万
成交额
--
52周最高
32.34
52周最低
16.60
市值
9.02亿
市盈率(TTM)
-76.4823
分时
5日
1月
3月
1年
5年
医用胶粘剂市场-行业需求、全球研究、新兴趋势、投资机会和到 2028 年的收入预期
Research Nester has released a report titled "" which delivers detailed overview of the globalmedical adhesive market in terms of market segmentation by product type, application, and by region.
AmericaNewsHour · 4天前
外科密封剂和粘合剂市场规模,按形式的共享和趋势分析报告,按应用,按地区和细分市场预测,2020 – 2028
The are segmented on the lines of its application, product, indication and regional. Based on application segmentation it covers central nervous system (CNS) surgeries, general surgeries, cardiovascular surgeries, orthopedic surgeries, cosmetic surgeries,...
Heraldkeepers · 6天前
医用胶粘剂市场-全球行业分析、规模、份额、增长、趋势和到 2028 年的预测
Research Nester has released a report titled " " which delivers detailed overview of the globalmedical adhesive market in terms of market segmentation by product type, application, and by region.
AmericaNewsHour · 09/20 06:53
CryoLife 将参加摩根士丹利第 19 届年度全球医疗保健会议
/PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Morgan Stanley 19 Annual Global Healthcare Conference on . The Company's virtual ...
PR Newswire - PRF · 08/31 20:25
未公开潜在混合货架产品尺寸的 BRIEF-CryoLife 文件
reuters.com · 08/11 22:12
CryoLife 将参加即将举行的虚拟投资者会议
/PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming virtual investor conferences.
PR Newswire - PRF · 08/02 20:30
2021 年人工心脏瓣膜市场规模按趋势评估、领先者更新、消费者需求、消费、最新发展、战略、市场影响和到 2027 年的预测
The scope of the report includes a detailed study of global and regional markets for various Prosthetic Heart Valves Market with the reasons given for variations in the growth of the industry in certain regions.
Heraldkeepers · 07/30 18:54
哪种类型的股东拥有最多的 CryoLife, Inc. (NYSE:CRY) 股票?
Every investor in CryoLife, Inc. ( NYSE:CRY ) should be aware of the most powerful shareholder groups. Institutions...
Simply Wall St. · 07/30 07:18
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解CRY最新的财务预测,通过CRY每股收益,每股净资产,每股现金流等数据分析CryoLife近期的经营情况,然后做出明智的投资选择。
分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

50.00%强力推荐
25.00%买入
25.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测CRY价格均价为34.19,最高价位39.00,最低价为30.75。
最高39.00
均价34.19
最低30.75
现价22.96
EPS
实际EPS
预期EPS
-0.020.050.110.18
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q3 2021
机构持股
总机构数: 195
机构持股: 3,531.54万
持股比例: 89.85%
总股本: 3,930.63万
类型机构数股数
增持
42
64.05万
建仓
16
35.31万
减持
46
117.74万
平仓
10
19.18万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
医疗设备、用品及经销
-2.18%
医疗设备和用品
-2.60%
高管信息
Chairman/President/Chief Executive Officer/Director
James Mackin
Chief Financial Officer/Chief Operating Officer/Executive Vice President
D. Ashley Lee
Senior Vice President/Chief Compliance Officer/General Counsel/Secretary
Jean Holloway
Senior Vice President/Director of Sales/Director of Marketing
John Davis
Chief Accounting Officer/Vice President
Amy Horton
Vice President - Operations
Dennis Maier
Vice President/Director of Human Resources
Matthew Getz
Vice President
F. Peter Barthold
Vice President
Scott Capps
Independent Director
Thomas Ackerman
Independent Director
Daniel Bevevino
Independent Director
Marna Borgstrom
Independent Director
James Bullock
Independent Director
Jeffrey Burbank
Independent Director
Jon Salveson
公告日期
每股分红
除权日期
2015/10/23
Dividend USD 0.03
2015/12/09
2015/07/22
Dividend USD 0.03
2015/09/09
2015/05/22
Dividend USD 0.03
2015/06/10
2015/02/13
Dividend USD 0.03
2015/03/11
2014/10/23
Dividend USD 0.03
2014/12/10
2014/07/30
Dividend USD 0.03
2014/09/10
2014/05/23
Dividend USD 0.03
2014/06/11
2014/02/20
Dividend USD 0.027
2014/03/12
2013/11/21
Dividend USD 0.027
2013/12/11
2013/08/21
Dividend USD 0.027
2013/09/11
2013/05/28
Dividend USD 0.027
2013/06/12
CRY 简况
CryoLife Inc(CryoLife)是一家医疗器械公司。该公司制造、加工和分销用于主动脉疾病患者心脏和血管外科手术的医疗器械和可植入人体组织。该公司运营两个业务部门:医疗器械部门和保存服务部门。医疗器械部门包括医疗器械,如外科密封剂、BioGlue产品、JOTEC产品、On-X产品、CardioGenesis心脏激光疗法、PhotoFix和NEXUS。保存服务部门的收入来自心脏和血管植入性人体组织保存服务。

微牛提供Cryolife Inc(NYSE-CRY)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的CRY股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易CRY股票基本功能。